Contrarily, AT-001 treatment did not influence the myocardial expression of MMP9 and MMP7 (Fig. 4g, h), both of which are potent regulators of cardiac fibrosis and hypertrophy [28]. The gene discussed is MMP9; the disease is cardiac hypertrophy.